Proto Labs Stock Price and Value Analysis

Proto Labs (NYSE:PRLB) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Proto Labs to reach your target.

Target type

PRLB Free Cash Flow Trend

Free Cash Flow trendline for PRLB
Free Cash Flow trendline for Proto Labs
CSV

Based on historical returns, we believe that Proto Labs can grow its free cash at a rate of about 7%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a decent rate.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the PRLB Numbers

PRLB Price
(Proto Labs stock price per share)
$57.52
[?] PRLB Fair Price
(based on intrinsic value)
$28.23
[?] PRLB Safety Price (based on a variable margin of safety) $16.94
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 204% higher than other Industrials stocks
[?] PE Ratio versus Industry 67% higher than other Metal Fabrication stocks
[?] Free Cash Flow Jitter 55%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 616,285 shares shorted. With 23,594,961 shares available for purchase and an average trading volume over the past 10 trading days of 260,560, it would take at least 2.4 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2010 1443669 6.9
2011 1443669 10.5
2012 1443669 10.8
2013 1443669 32.9
2014 1443669 36.1
2015 1443669 35.5
2016 1443669 46
2017 1443669 47.2
2018 1443669 74.7
2019 1443669 64.1
2020 1443669 54.5
2021 1443669 2.6
2022 1443669 11.6
2023 1443669 34.6
2024 1443669 49.8
2025 1443669 52.9

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 15 fiscal years from 2010 to 2025 with positive net income, operating cash flow totaled $1,019 million against net income of $550 million, or 1.85 times. Net income was negative in 1 of the 16 years, and those years are left out of the ratio.

In 2025, operating cash flow was 3.51 times net income, compared with 1.19 times for the earliest three years (2010 to 2012).

In 2025, capital expenditures were $14.8 million, 19.9% of operating cash flow of $74.5 million, which leaves an estimated $59.7 million after capex. Across the 16 years with reported capex, it averaged 48.2% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2010 11 14 7.1 1.28
2011 18 23.5 19 1.31
2012 24 25.3 17.4 1.05
2013 35.3 48.4 18.8 1.37
2014 41.6 57.2 43.5 1.37
2015 46.5 64.1 44.4 1.38
2016 42.7 77.5 33.6 1.81
2017 51.8 81.7 32.6 1.58
2018 76.6 123 87.1 1.61
2019 63.7 116 62.2 1.82
2020 50.9 107 47 2.10
2021 33.4 55.2 34.2 1.66
2022 -103 62.1 21.7 n/a
2023 17.2 73.3 28.1 4.26
2024 16.6 77.8 9.2 4.69
2025 21.2 74.5 14.8 3.51

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 9 fiscal years from 2017 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $392 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In 9 of the 9 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $265 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, cash spent repurchasing shares was $43 million, 81.2% of estimated free cash flow of $52.9 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2017 47.2 n/a 4.4 4.4 9.3%
2018 74.7 n/a 12.2 12.2 16.4%
2019 64.1 n/a 33.5 33.5 52.3%
2020 54.5 n/a 14.7 14.7 27.0%
2021 2.6 n/a 23.3 23.3 893.8%
2022 11.6 n/a 29.7 29.7 255.0%
2023 34.6 n/a 44 44 126.9%
2024 49.8 n/a 60.3 60.3 121.1%
2025 52.9 n/a 43 43 81.2%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $64.9 million in 2010 and $533 million in 2025, a compound annual growth rate of 15.1% over 15 years.

Revenue rose 6.4% from 2024 to 2025.

Our estimated free cash flow was $52.9 million in 2025, 9.9% of revenue. In 2010 the estimated margin was 10.7%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2010 64.9 6.9 10.7%
2011 98.9 10.5 10.6%
2012 126 10.8 8.6%
2013 163 32.9 20.2%
2014 210 36.1 17.2%
2015 264 35.5 13.4%
2016 298 46 15.4%
2017 344 47.2 13.7%
2018 446 74.7 16.8%
2019 459 64.1 14.0%
2020 434 54.5 12.5%
2021 488 2.6 0.5%
2022 488 11.6 2.4%
2023 504 34.6 6.9%
2024 501 49.8 9.9%
2025 533 52.9 9.9%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $111 million against total liabilities of $89.5 million, or 123.9% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 11.7% of total assets in 2025, compared with 132.5% in 2011, a decrease of 120.8 percentage points.

Stockholders equity was $674 million in 2025, up from negative equity of -$20.2 million in 2011.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 9.0% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2011 62.3 8.1 82.6 -20.2
2012 173 36.8 16 157
2013 230 43 18.5 212
2014 287 43.3 21.5 266
2015 361 47.7 33.4 328
2016 414 68.8 34.4 380
2017 519 36.7 57.5 461
2018 619 85 77.5 541
2019 674 125 87.9 586
2020 744 128 99.8 644
2021 929 65.9 100 828
2022 802 56.6 105 698
2023 772 83.8 77.1 695
2024 744 89.1 73.4 670
2025 763 111 89.5 674

Price Versus Our Estimated Value

Free cash flow was positive in all 16 fiscal years we have for Proto Labs under its current SEC filer.

Average free cash flow over the last three years of data was $45.8 million, and across the first three years it was $9.4 million; over the period it rose sharply.

Year-to-year variability in free cash flow is volatile, measured at 55%.

Proto Labs is priced at $57.52, above our fair value estimate of $28.23 and its safe value of $16.94.

No dividend yield is recorded for Proto Labs in our data.

Our value investing guide explains how to test these numbers against the filings themselves.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 204% above the average for stocks in the Industrials sector.

Its trailing P/E ratio is 67% above the average for stocks in the Metal Fabrication industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Metal Fabrication industry, the ones closest in market capitalization to Proto Labs, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Proto Labs (PRLB) 1,373 39.9 - - 104% above
Park-Ohio Holdings Corp. (PKOH) 592 16.2 1.2% 6.2% 32% below
AZZ (AZZ) 3,512 22.0 0.7% 4.3% 14% below
Mueller Water Products (MWA) 3,674 16.8 1.2% 3.0% 27% above
Materion Corporation (MTRN) 3,806 37.4 0.3% - 342% above
Valmont Industries (VMI) 7,382 14.4 0.7% 4.3% 3% below
Watts Water Technologies (WTS) 11,541 25.9 0.6% 1.2% 99% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1443669.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: PRLB annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in PRLB

Does Proto Labs have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: PRLB

This example shows how we apply the Trendshare checklist to PRLB: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 57.52
    • Market cap: $1.4B
    • EPS: 1.44
  2. Step 2 — Valuation checks

    • P/E: 39.944
    • FCF yield: —
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.